Pharma Reviews: Should long-term investors go for primary market offerings?

There are a few interesting midcap pharma companies as well. The likes of Granules India or Suven Pharma and even Laurus Labs. There is a lot of ...
Read more: Should long-term investors go for primary market offerings?

Pharma Reviews: There is a greater need now for quick results without any compromise on efficacy and patient safety ...

... and patient safety : Sridhar Venkatesh, Managing Director, GSK India ... The important lesson the pharma industry has learnt is that much more can ...
Read more: There is a greater need now for quick results without any compromise on efficacy and patient safety ...

Pharma Reviews: Top headlines: FM says recovery patch; after LVB crisis at Dhanlaxmi Bank

As clinical trials for a Covid-19 vaccine get underway, Indian pharma companies are either repurposing existing capacity or sacrificing capacity for ...
Read more: Top headlines: FM says recovery patch; after LVB crisis at Dhanlaxmi Bank

Pharma Reviews: US hails India partnership as crucial for global recovery from Covid-19

“American company, Gilead has granted voluntary non-exclusive licensing agreements to Indian pharmaceutical companies to produce a generic form ...
Read more: US hails India partnership as crucial for global recovery from Covid-19

Pharma Reviews: Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Speaking at the Confederation of Indian Industry's Life Science Conclave 2020, Suresh Jadhav, executive director of the Serum Institute of India (SII), ...
Read more: Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Pharma Reviews: Are India's pharma regulations denting patient interests?

Domestic manufacturers further assert that they can suffice the needs of pharmaceutical companies in India at a competitive price.Thus, India can curb ...
Read more: Are India's pharma regulations denting patient interests?

Pharma Reviews: Pharma company Panacea Biotec gets warning letter from USFDA for Baddi facility

New Delhi: Drug firm Panacea Biotec on Wednesday said it has received a warning letter from the US health regulator for its pharmaceutical ...
Read more: Pharma company Panacea Biotec gets warning letter from USFDA for Baddi facility

Pharma Reviews: Indian shares flat as gains in pharma, Reliance offset losses in banks

The Nifty pharma index rose 1.75%. Reliance Industries Ltd was the top boost to the Nifty 50 index, gaining nearly 1%, after the company said U.S. fund ...
Read more: Indian shares flat as gains in pharma, Reliance offset losses in banks

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 30, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 30, 2020

US FDA News: Potential Risk of Infection during Cardiac Surgery When Using the CardioQuip Modular Cooler-Heater Device – Letter to Health Care Providers

The FDA is providing new information about the risk of NTM infections in patients who have undergone cardiothoracic surgeries using heater-cooler devices.
Read more: Potential Risk of Infection during Cardiac Surgery When Using the CardioQuip Modular Cooler-Heater Device – Letter to Health Care Providers

US FDA News: DMM VISSION, S.A. DE C.V. Issues Voluntary Nationwide Recall of Cleaner Hand Sanitizer 500 mL and 1200 mL Bottles Due to the Possible Presence of Undeclared Methanol (Wood Alcohol)

Estado de México, México, DMM VISSION, S.A. de C.V. is voluntarily recalling five lots of Cleaner Hand Sanitizer, 500 mL and 1,200 mL plastic clear bottles with white tops currently in US distribution to the consumer level. This recall is being initiated out of abundance of caution due to detection
Read more: DMM VISSION, S.A. DE C.V. Issues Voluntary Nationwide Recall of Cleaner Hand Sanitizer 500 mL and 1200 mL Bottles Due to the Possible Presence of Undeclared Methanol (Wood Alcohol)

Pharma Reviews: Investments in R&D, technology can make Indian pharma industry atma nirbhar in the next 2-3 ...

He said that with its potential, the Indian pharma sector is going to be a $65 billion industry by 2025 and touch $1.25 billion by 2030. The minister also ...
Read more: Investments in R&D, technology can make Indian pharma industry atma nirbhar in the next 2-3 ...

Pharma Reviews: Market LIVE: Sensex, Nifty choppy; FMCG, pharma stocks offset losses in banks

This comes in the backdrop of the state-run conventional power generation firm rewriting its playbook, given that India's energy landscape is rapidly ...
Read more: Market LIVE: Sensex, Nifty choppy; FMCG, pharma stocks offset losses in banks

Pharma Reviews: Centaur Pharma launches WOXHeal for treatment of diabetic foot ulcer

The data and outcomes of the trial were submitted to the Indian Regulatory Authority and a manufacturing and marketing approval was granted to ...
Read more: Centaur Pharma launches WOXHeal for treatment of diabetic foot ulcer

Pharma Reviews: Don't bother much, Trump-Biden debate just soap opera: D-Street

Sameer Kalra, Founder at Target Investing, said from an Indian market's point of view, there are ... So, for the pharma industry, it plays out both ways.
Read more: Don't bother much, Trump-Biden debate just soap opera: D-Street

Pharma Reviews: Kamaladevi Chattopadhyay NIF Book Prize longlist picks 12 power-packed titles

... book on the pharma industry, the books cover a wide and eclectic ground. ... The Kamaladevi Chattopadhyay New India Foundation Book Prize is named ... Bottle of Lies: Ranbaxy and the Dark Side of Indian Pharma by Katherine ...
Read more: Kamaladevi Chattopadhyay NIF Book Prize longlist picks 12 power-packed titles

Pharma Reviews: Trade war offers new opportunities for Indian specialty chemical firms

For instance, industry reports peg the Indian pharma industry's dependence on China for Active Pharmaceutical Ingredients (API) at 60-70 per cent.
Read more: Trade war offers new opportunities for Indian specialty chemical firms

Pharma Reviews: Market LIVE Updates: Indices flat with Nifty around 11200; RIL, pharma stocks in focus

Market Opens: Indian indices opened marginally lower on September 30 with Nifty around 11200. At 09:16 IST, the Sensex was down 27.21 points or ...
Read more: Market LIVE Updates: Indices flat with Nifty around 11200; RIL, pharma stocks in focus

Pharma Reviews: Punit Bansal one of the best analyser of Indian pharma industry and who has vast knowledge of ...

punit Bansal is active on twitter and is probably the best analyst on whole pharma industry ....He is all praises for laurus labs and sees it a giant from ...
Read more: Punit Bansal one of the best analyser of Indian pharma industry and who has vast knowledge of ...

Pharma Reviews: Government begins anti-dumping probe into pharma imports

Pharma sector sources point out that China's economies of scale result in 20-30 per cent cheaper prices ... DGTR said the probe has been initiated due to a report filed by Indian pharma firms Nectar Life Sciences and Sterile India.
Read more: Government begins anti-dumping probe into pharma imports

US FDA News: FDA Issues Final Guidance for Certain Labeling Recommendations for Breast Implants

FDA issued guidance for certain labeling recommendations for breast implants as part of the agency’s effort to improve the information available to patients and health care professionals about the risks of breast implants.
Read more: FDA Issues Final Guidance for Certain Labeling Recommendations for Breast Implants

Pharma Reviews: As domestic sales decline, drug makers focus on exports to sustain growth

Exports are helping pharmaceutical (pharma) companies sustain the growth ... Indian companies are also tapping new opportunities in Latin America.
Read more: As domestic sales decline, drug makers focus on exports to sustain growth

Pharma Reviews: Market LIVE Updates: Indices near day's high with Nifty above 11100; ONGC top gainer

Rupee Opens: Indian rupee opened lower at 73.67 per dollar on Monday against Friday's close of 73.61, amid buying seen in the domestic equity ...
Read more: Market LIVE Updates: Indices near day's high with Nifty above 11100; ONGC top gainer

Pharma Reviews: PM Modi presents upbeat, forward-looking Indian agenda at UN

Modi said the Indian pharma industry had sent essential medicines to more than 150 countries. "As the largest vaccine-producing country of the world, ...
Read more: PM Modi presents upbeat, forward-looking Indian agenda at UN

Pharma Reviews: Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Drug major Sun Pharma is looking to expand its specialty business across ... Sharing information with shareholders, Sun Pharmaceutical Industries ... Panel experts will come together to discuss, enablement of a healthier India.
Read more: Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Pharma Reviews: Our new Bonthapally facility can be central warehousing hub for Covid-19 vaccine: Gubba Kiran

Seven Indian pharmaceutical companies such as Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and ...
Read more: Our new Bonthapally facility can be central warehousing hub for Covid-19 vaccine: Gubba Kiran

Pharma Reviews: India launches programme to strengthen clinical trial research capacity of vaccines in neighbouring ...

The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm said ...
Read more: India launches programme to strengthen clinical trial research capacity of vaccines in neighbouring ...

Pharma Reviews: Latest News Live: Shiromani Akali Dal announces exit from NDA over agri ordinances

Even during these very difficult times of the raging pandemic, the pharmaceutical industry of India has sent essential medicines to more than 150 ...
Read more: Latest News Live: Shiromani Akali Dal announces exit from NDA over agri ordinances

Pharma Reviews: The formula to step up India Nutra Inc's success

Three big industries (foods, ingredients, and pharma) are looking at strategies to augment their capabilities in the nutraceuticals market. But, this ...
Read more: The formula to step up India Nutra Inc's success

Pharma Reviews: PM Modi at UNGA: 'How long will India be kept out of decision-making structures of UN'

In this challenging time of the pandemic, India's pharma industry has sent essential medicines to more than 150 countries. As the world's largest ...
Read more: PM Modi at UNGA: 'How long will India be kept out of decision-making structures of UN'

Pharma Reviews: Dr Reddy's launches generic drug to treat multiple sclerosis in US

The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm ...
Read more: Dr Reddy's launches generic drug to treat multiple sclerosis in US

Pharma Reviews: PM Modi address to UNGA LIVE updates: India's vaccine production and delivery capacity will be ...

We treat the whole world as a family," PM Modi said, adding that during the COVID-19 pandemic, India's pharma industry has sent medicines to over ...
Read more: PM Modi address to UNGA LIVE updates: India's vaccine production and delivery capacity will be ...

Pharma Reviews: We will soon have a pharma vertical led by expert professionals: Snowman CEO Sunil Nair

A fragmented market with low visibility of the cold chain - Indian pharmaceutical industry is highly fragmented and price sensitive. Pharmaceutical ...
Read more: We will soon have a pharma vertical led by expert professionals: Snowman CEO Sunil Nair

Pharma Reviews: Ethical doctors question government over U-turn on code for pharma companies

A key feature of the code is that no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised by a pharma company to ...
Read more: Ethical doctors question government over U-turn on code for pharma companies

Pharma Reviews: Credit metrics of leading pharma companies to remain stable: ICRA

New Delhi [India], Sep 26 (ANI): The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic ...
Read more: Credit metrics of leading pharma companies to remain stable: ICRA

Pharma Reviews: 'Hyderabad Pharma City to attract investments'

Several pharma companies such as Granules India, Laurus Labs, MSN ... Indian pharma attracted FDI worth Rs 3,649.8 crore ($517.79 million) in ...
Read more: 'Hyderabad Pharma City to attract investments'

Pharma Reviews: Incentives not enough, bulk drug industry seeks level-playing field to make India 'Atma Nirbhar'

Unless countered with very quick anti-dumping measures, it may turn the production of such items unsustainable for Indian industry. There is a need for ...
Read more: Incentives not enough, bulk drug industry seeks level-playing field to make India 'Atma Nirbhar'

Pharma Reviews: On the frontlines

Indian pharma companies have the opportunity of emerging as an alternative low-cost option for drug supplies to the world, if the industry, with some ...
Read more: On the frontlines

Pharma Reviews: Review: Government body calls for self-reliance in Active Pharmaceutical Ingredients (APIs)

The Indian pharma industry is heavily reliant on imports for APIs and more than 2/3^rd of the ... India's pharmaceutical is among the largest in the world.
Read more: Review: Government body calls for self-reliance in Active Pharmaceutical Ingredients (APIs)

Pharma Reviews: No feverish pace, government recruitments frozen for the last 6 months

Over the last six to seven months, except for essential medical services, ... Ashoka told The New Indian Express that over the years, officials have plotted ... recruitments have taken place across sectors, except in the pharma industry.
Read more: No feverish pace, government recruitments frozen for the last 6 months

Pharma Reviews: The key role of CSIR in the battle against Covid | Opinion

A few days ago, the Drugs Controller General of India (DCGI) formally ... Similarly, the generic pharma industry might recollect the years when CSIR ...
Read more: The key role of CSIR in the battle against Covid | Opinion

US FDA News: FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years

Today FDA approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.
Read more: FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

FDA issues an updated summary of the agency’s COVID-19 response efforts.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

US FDA News: Mammography Problems at Allison Breast Center at Monument Radiology in Richmond, Virginia: FDA Safety Communication

Mammography Problems at Allison Breast Center at Monument Radiology
Read more: Mammography Problems at Allison Breast Center at Monument Radiology in Richmond, Virginia: FDA Safety Communication

Pharma Reviews: Higher exports to help pharma eke out 8-9% growth this fiscal

New Delhi, Sep 24 (IANS) Living up to its moniker of a defensive bet, the Rs 2.8 lakh crore Indian pharmaceutical sector is set to emerge more or less ...
Read more: Higher exports to help pharma eke out 8-9% growth this fiscal

Pharma Reviews: Which stocks to buy amid share market correction: As Sensex plunges, bet on these sectors | Geojit ...

On the sectoral front, he sees consumption and pharma sectors most stable sectors in the Indian industry and holds a positive view on them. During ...
Read more: Which stocks to buy amid share market correction: As Sensex plunges, bet on these sectors | Geojit ...

Pharma Reviews: Indian Healthcare Urgently Needs a Robust Cyber-Security Framework

The Healthcare sector of India is currently rated as the sixth-largest market globally as predicted by Indian Pharmaceutical Congress, and it has also ...
Read more: Indian Healthcare Urgently Needs a Robust Cyber-Security Framework

Pharma Reviews: Higher exports to help pharma eke out 8-9% growth this fiscal: CRISIL

Living up to its moniker of a defensive bet, the Rs 2.8 lakh crore Indian pharmaceutical sector is set to emerge more or less unscathed from the ...
Read more: Higher exports to help pharma eke out 8-9% growth this fiscal: CRISIL

US FDA News: FDA Takes Actions to Help Lower U.S. Prescription Drug Prices

Today, HHS and FDA took actions to help provide safe, effective, and more affordable drugs to American patients by completing the rulemaking to allow states to import certain prescription drugs from Canada.
Read more: FDA Takes Actions to Help Lower U.S. Prescription Drug Prices

US FDA News: Benadryl (diphenhydramine): Drug Safety Communication - Serious Problems with High Doses of the Allergy Medicine

FDA is warning that taking higher than recommended doses of the common over-the-counter (OTC) allergy medicine Benadryl (diphenhydramine) can lead to serious heart problems, seizures, coma, or even death.
Read more: Benadryl (diphenhydramine): Drug Safety Communication - Serious Problems with High Doses of the Allergy Medicine

Pharma Reviews: 'Hyderabad Pharma City to attract investments'

Speaking about the growth pattern, Srinivas N, MD, Industrial and Logistics, Savills India, said, “New investments in Hyderabad by pharma companies ...
Read more: 'Hyderabad Pharma City to attract investments'

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020

Product Recall Alerts: Riomet ER Recalled Due to NDMA Concerns

Reference. Sun Pharmaceutical Industries, Inc. issues voluntary nationwide recall of Riomet ER™ (metformin hydrochloride for extended-release oral ...
Read more: Riomet ER Recalled Due to NDMA Concerns

Pharma Reviews: Indian pharma sector set to emerge stronger due to higher exports

Higher exports are likely to help the Indian pharma sector to garner upto eight to nine per cent growth this fiscal. It is expected that the Rs 2.8 lakh ...
Read more: Indian pharma sector set to emerge stronger due to higher exports

US FDA News: FDA Issues Recommendations for Certain High-Risk Groups Regarding Mercury-Containing Dental Amalgam

FDA issues updated recommendations on dental amalgam and potential risks to certain high-risk individuals that may be associated with mercury-containing fillings used to restore the missing structure and surfaces of a decayed tooth.
Read more: FDA Issues Recommendations for Certain High-Risk Groups Regarding Mercury-Containing Dental Amalgam

US FDA News: Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication

The FDA is providing recommendations for certain high-risk populations may be more vulnerable to potential adverse health effects of mercury exposure from dental amalgam.
Read more: Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication

Pharma Reviews: Pharma to beat COVID-19 blues: Higher exports to help sector eke out 8-9% growth this fiscal

While the coronavirus pandemic has ravaged Indian economy along with several sectors, the domestic pharmaceutical industry is expected to beat the ...
Read more: Pharma to beat COVID-19 blues: Higher exports to help sector eke out 8-9% growth this fiscal

Pharma Reviews: Sensex, Nifty end 3% lower amid global meltdown; Investors lose ₹3.73 trillion

Indian stocks continued the downward trajectory for sixth straight session with ... Led by this, market capitalisation of the BSE listed firms dropped to ... Drug firm Zydus Cadila on Thursday said it has received tentative approval from ...
Read more: Sensex, Nifty end 3% lower amid global meltdown; Investors lose ₹3.73 trillion

Pharma Reviews: Indian exports start recovering while imports remain subdued: Maersk

The Indian pharmaceutical industry is expected to grow around 10 percent to 12 percent in the next couple of years owing to the efforts taken by the ...
Read more: Indian exports start recovering while imports remain subdued: Maersk

Product Recall Alerts: Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER ...

Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of ... When a company announces a recall, market withdrawal, or safety alert, the FDA posts ... The product was distributed nationwide to wholesale customers.
Read more: Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER ...

Product Recall Alerts: Perrigo Recalls All Albuterol Sulfate Inhalers

Specifically, some of the inhalers may not dispense the medication due to a clogging issue. ... FDA alerts of Perrigo's voluntary albuterol inhaler recall.
Read more: Perrigo Recalls All Albuterol Sulfate Inhalers

Pharma Reviews: Can't directly deal with complaints of unethical practices: Department of pharmaceuticals

... of the associations including Indian Pharmaceutical Assocaition (IPA)-that represent the top pharma companies, Organisation of Pharmaceutical ...
Read more: Can't directly deal with complaints of unethical practices: Department of pharmaceuticals

Pharma Reviews: Pharma Inc, Climate Change, Decarbonisation

There are no generic companies in this list and no Indian pharma company yet. Why are climate change and de-carbonisation not a big deal yet for ...
Read more: Pharma Inc, Climate Change, Decarbonisation

Pharma Reviews: Self-reliance and the patient

They claim, as per reports, China is flooding the Indian market with Vitamin C medicines. They further argue that when they can meet the needs of ...
Read more: Self-reliance and the patient

Pharma Reviews: As China hikes prices of pharma KSMs, India's atmanirbhar drive faces its first real test

The latest move by China is being viewed by some analysts as a ploy to derail the Indian pharmaceutical industry's push to align itself with the vision ...
Read more: As China hikes prices of pharma KSMs, India's atmanirbhar drive faces its first real test

Pharma Reviews: Kool-ex Partners With IndoSpace to Build Customized Pharma Distribution Centres, Across the ...

Kool-ex partners with India's largest industrial and logistics real estate developer, IndoSpace, to build customized, GDP/GWP compliant, temperature ...
Read more: Kool-ex Partners With IndoSpace to Build Customized Pharma Distribution Centres, Across the ...

Pharma Reviews: 42 stocks from 2 sectors that doubled money in 2020 still have more steam

There is going to be incremental demand for multiple pharmaceutical ... The regulatory hurdle was one of the biggest challenges for Indian pharma ...
Read more: 42 stocks from 2 sectors that doubled money in 2020 still have more steam

Pharma Reviews: Stock Market Highlights: Sensex, Nifty end in red for fifth day; media index slips over 2%, Bharti ...

The Indian benchmark equity indices, Sensex and Nifty ended Wednesday's volatile session lower dragged by selling in banks, pharma and media ...
Read more: Stock Market Highlights: Sensex, Nifty end in red for fifth day; media index slips over 2%, Bharti ...

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes First Point-of-Care Antibody Test for COVID-19

Today, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes First Point-of-Care Antibody Test for COVID-19

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 23, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 23, 2020

US FDA News: Benzodiazepine Drug Class: Drug Safety Communication - Boxed Warning Updated to Improve Safe Use

The FDA is requiring the Boxed Warning be updated by adding other information to the prescribing information for all benzodiazepine medicines. This information will describe the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions across all the medicines in the class.
Read more: Benzodiazepine Drug Class: Drug Safety Communication - Boxed Warning Updated to Improve Safe Use

US FDA News: FDA Requiring Labeling Changes for Benzodiazepines

FDA issues a Drug Safety Communication announcing a class-wide labeling change for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
Read more: FDA Requiring Labeling Changes for Benzodiazepines

US FDA News: Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason for the recall is due to
Read more: Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

US FDA News: FDA Achieves Key Milestone, Finalizes Framework That Will Resume Shellfish Trade with Europe for the First Time in 10 Years

FDA finalized a molluscan shellfish equivalence determination for two European Union (EU) Member States, Spain and the Netherlands
Read more: FDA Achieves Key Milestone, Finalizes Framework That Will Resume Shellfish Trade with Europe for the First Time in 10 Years

Pharma Reviews: Like IT sector in the past, everything's coming together for pharma now: GV Prasad

India is well positioned to be a dominant force in the global generics industry and that is showing. GV Prasad of Dr Reddy's on Russian vaccine, ...
Read more: Like IT sector in the past, everything's coming together for pharma now: GV Prasad

US FDA News: FDA Launches the Digital Health Center of Excellence

FDA launches the Digital Health Center of Excellence within CDRH, furthering FDA’s dedication to the advancement of digital health technology - including mobile health devices, Software as a Medical Device, wearables when used as a medical device, and technologies used to study medical products.
Read more: FDA Launches the Digital Health Center of Excellence

US FDA News: FDA Clarifies Types of Evidence Relevant to Determining the “Intended Use” of FDA-Regulated Products

FDA proposal to clarify regulations about the types of evidence relevant to determining how a manufacturer intends for its product to be used by health care providers and patients, an area known as intended use.
Read more: FDA Clarifies Types of Evidence Relevant to Determining the “Intended Use” of FDA-Regulated Products

Pharma Reviews: Anarock partners US-based Binswanger for consultancy services in industrial, logistics spaces

Further, there is a growing trend amongst high export industries such as Indian pharma to look at expansion to the US and other countries, he added.
Read more: Anarock partners US-based Binswanger for consultancy services in industrial, logistics spaces

Pharma Reviews: Binswanger Partners With ANAROCK To Offer Focused Industrial Realty Services

to ramp up capacities in India. Further, there is a growing trend amongst high export industries such as Indian Pharma to look at expansion to US and ...
Read more: Binswanger Partners With ANAROCK To Offer Focused Industrial Realty Services

Pharma Reviews: China hikes prices of drug ingredients; raises concerns in Indian pharma industry

The pharmaceutical market in India, among the leading producers of drugs in the world, is largely dependent on imports of KSMs and APIs from China ...
Read more: China hikes prices of drug ingredients; raises concerns in Indian pharma industry

Pharma Reviews: Haryana showcases readiness to bid for bulk drugs and medical device parks at PHDCCI webinar

To make Indian industry competitive, the Government of India is giving preference to high scale and high-quality manufacturing. He also informed that ...
Read more: Haryana showcases readiness to bid for bulk drugs and medical device parks at PHDCCI webinar

Pharma Reviews: Coronavirus vaccine likely to be ready for India next year, says scientist

In India, Prime Minister Narendra Modi's government had promised an indigenous ... by major western pharmaceutical companies, had a 50% chance of success. ... Serum Institute of India, the world's largest vaccine manufacturer, ...
Read more: Coronavirus vaccine likely to be ready for India next year, says scientist

Pharma Reviews: SPARC licenses commercialisation rights of anti-epileptic drug to Tripoint Therapeutics

New Delhi: Sun Pharma Advanced Research Company (SPARC) on ... Drug User Fee Act) fees for Elepsia XR 1,000 mg and Elepsia XR 1,500 mg.
Read more: SPARC licenses commercialisation rights of anti-epileptic drug to Tripoint Therapeutics

Pharma Reviews: China increases prices of key drug ingredients by up to 20%, likely to put pressure on Indian ...

New Delhi: At a time the drug industry is grappling with the coronavirus pandemic, India's pharmaceutical companies are likely to confront a new ...
Read more: China increases prices of key drug ingredients by up to 20%, likely to put pressure on Indian ...

US FDA News: BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error

Three of the recalls, which BD announced on Aug. 4, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that FDA has determined that there is a reasonable probability that the use of the product will cause serious adverse health consequences or d
Read more: BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error

Pharma Reviews: China hikes prices of key drug ingredients

Both KSMs and APIs are imported in India for making life-saving antibiotics, ... Indian Drug Manufacturers' Association president Mahesh Doshi said, ...
Read more: China hikes prices of key drug ingredients

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 21, 2020

FDA’s actions on a new video for consumers and an updated guidance in its ongoing response to the COVID-19 pandemic.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 21, 2020

Pharma Reviews: Difficult pathways for Atma Nirbhar Bharat

These are beneficial when there is demand in the market. ... He has said that the primary reason for the Indian Pharma industry sourcing material from ...
Read more: Difficult pathways for Atma Nirbhar Bharat

Pharma Reviews: Indian economy can touch $10 trillion in next 15 years: HUL CMD Sanjiv Mehta

Pharma industry is about USD 41 billion and we have around 3 per cent of the global pharma industry. This is a great opportunity to start looking to ...
Read more: Indian economy can touch $10 trillion in next 15 years: HUL CMD Sanjiv Mehta

Pharma Reviews: Tariff, non-tariff measures to protect India's interests: Piyush Goyal

He said Indian pharma companies have secured 31% of the market authorizations granted by USFDA in 2019 -20, which shows that Indian ...
Read more: Tariff, non-tariff measures to protect India's interests: Piyush Goyal

US FDA News: FDA Announces Key FSMA Rule to Advance Traceability of Foods, A Major Milestone in the New Era of Smarter Food Safety

The FDA has proposed a new rule that lays the foundation for end-to-end food traceability across the food industry that we’ll be working toward over the next decade as part of the New Era of Smarter Food Safety initiative.
Read more: FDA Announces Key FSMA Rule to Advance Traceability of Foods, A Major Milestone in the New Era of Smarter Food Safety

Pharma Reviews: Dolat Capital: Sun Pharma's Investments To Build A Branded Specialty Business - A Key ...

Signage is displayed at the Sun Pharmaceutical Industries Ltd. headquarters in Mumbai, India. (Photographer: Kanishka Sonthalia/Bloomberg) ...
Read more: Dolat Capital: Sun Pharma's Investments To Build A Branded Specialty Business - A Key ...

Pharma Reviews: Market Live Updates: Sensex tumbles 700 pts, Nifty cracks below 11300; metal & pharma indices ...

Bet on these 4 key sectors in uncertain times as India may witness K-shaped ... Among the sectors, auto, FMCG, pharma and metals are down over 2 ...
Read more: Market Live Updates: Sensex tumbles 700 pts, Nifty cracks below 11300; metal & pharma indices ...

Pharma Reviews: DAILY VOICE | Too many IPOs squeeze out liquidity from market causing correction: Umesh Mehta ...

On the other hand, Indian Pharma companies are well placed to take on several opportunities arising due to drug shortages and reduced regulatory ...
Read more: DAILY VOICE | Too many IPOs squeeze out liquidity from market causing correction: Umesh Mehta ...

Pharma Reviews: Union Minister Gowda lauds contribution of Indian pharma industry amid COVID-19 crisis

Union Minister also stressed that the Indian pharma and medical devices industry was able to rise to the occasion. New Delhi: Union Minister for ...
Read more: Union Minister Gowda lauds contribution of Indian pharma industry amid COVID-19 crisis

Pharma Reviews: Punjab Govt hopeful that Bathinda would emerge as a venue of one of the three Pharmaceutical ...

Additionally, Bathinda has the All Indian Institute of Medical Sciences ... plant can be utilized in the pharma industry for to and fro traffic, he added.
Read more: Punjab Govt hopeful that Bathinda would emerge as a venue of one of the three Pharmaceutical ...

Pharma Reviews: Lincon sir & Vijay sir I request both of you to suggest best pick from pharma sector. Thanks a lot.

Whole pharma has been a stirring Sector and likely to continue bullish trends as Indian Pharma Industry will rule d Global needs. Do study ur self , it`s ...
Read more: Lincon sir & Vijay sir I request both of you to suggest best pick from pharma sector. Thanks a lot.

Pharma Reviews: Buzzing stock: Natco Pharma makes new 52-week high

Natco Pharma is an Indian pharmaceutical company based in Hyderabad, which makes finished dosage formulations and active pharmaceutical ...
Read more: Buzzing stock: Natco Pharma makes new 52-week high

Pharma Reviews: Both IT and pharma are in the midst of a bull run: Sudip Bandyopadhyay

Both IT and pharma are in the midst of a bull run: Sudip Bandyopadhyay ... Remember, pharma had two-and-a-half years of bear market and now it started ... was one of the biggest challenge for Indian pharma and that to an extent is ...
Read more: Both IT and pharma are in the midst of a bull run: Sudip Bandyopadhyay

Pharma Reviews: Manjiri Gharat elected as VP of FIP for 2020 – 2024

Manjiri Gharat, VP & Chairperson, Community Pharmacy Division of Indian Pharmaceutical Association (IPA), has been elected as Vice President of ...
Read more: Manjiri Gharat elected as VP of FIP for 2020 – 2024

Pharma Reviews: Hopeful that Bhatinda will emerge as venue for pharmaceutical parks in India: Punjab finance ...

... Badal on Friday said that he was hopeful that the Bhatinda Pharma Park would emerge as a venue of one of the three Pharmaceutical Parks in India ...
Read more: Hopeful that Bhatinda will emerge as venue for pharmaceutical parks in India: Punjab finance ...

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 18, 2020

FDA’s action on a reissued Emergency Use Authorization in its ongoing response to the COVID-19 pandemic.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 18, 2020

Pharma Reviews: Hopeful that Bhatinda will emerge as venue for pharmaceutical parks in India: Punjab finance ...

Hopeful that Bhatinda will emerge as venue for pharmaceutical parks in India: Punjab finance minister. ANI | Updated: Sep 18, 2020 23:47 IST.
Read more: Hopeful that Bhatinda will emerge as venue for pharmaceutical parks in India: Punjab finance ...

Pharma Reviews: Pharma stocks today have their best day in over a month. Cipla, Dr Reddy's surge

Indian stock markets gave up early gains to end lower today, led by losses in ... The pharmaceutical firm settled a patent litigation with U.S. drugmaker ...
Read more: Pharma stocks today have their best day in over a month. Cipla, Dr Reddy's surge

Pharma Reviews: Dr Reddy's Labs Rally 14 per cent Intra-Day, Becomes 2nd Most Valuable Indian Pharma ...

On Friday afternoon, Dr Reddy's Labs market cap stood at Rs 90,348 crore, BSE data shows. Sun Pharma is the most valued listed company of India ...
Read more: Dr Reddy's Labs Rally 14 per cent Intra-Day, Becomes 2nd Most Valuable Indian Pharma ...

Pharma Reviews: Bathinda Pharma Park would upheaval Chinese supremacy in medical field:Manpreet Badal

... of one of the three Pharmaceutical Parks in India, which will go a long way in rooting out the stranglehold of Chinese medicine manufacturing sector.
Read more: Bathinda Pharma Park would upheaval Chinese supremacy in medical field:Manpreet Badal

Pharma Reviews: Rs 25000 crore plan to cut dependence on China for key chemicals

India imports chemicals worth over Rs 1.5 lakh crore, of which around 85-90% ... These chemicals are used in manufacturing of active pharmaceutical ...
Read more: Rs 25000 crore plan to cut dependence on China for key chemicals

Pharma Reviews: Stock Market Highlights: Sensex ends 134 points lower, Nifty holds 11500; financials drag

Market Update | The Indian equity indices, Sensex and Nifty were trading higher on Friday afternoon led by gains in pharma, IT, metals and auto stocks.
Read more: Stock Market Highlights: Sensex ends 134 points lower, Nifty holds 11500; financials drag

Pharma Reviews: Market Highlights: Sensex ends 134 points lower, gives up 39000 mark, Nifty at 11516; banks ...

Sensex, Nifty fall for second day straight; Pharma stocks beat market blues, Natco ... India VIX opened at 20.10 levels but ended down at 19.94.
Read more: Market Highlights: Sensex ends 134 points lower, gives up 39000 mark, Nifty at 11516; banks ...

Pharma Reviews: Sceptre Medical India recognized as 'India's Most Admirable Healthcare Brand-2020' in the ...

Spectre has been a pioneer in the pharmaceutical and medical devices industry with its clients ranging over 65 hospitals like Max Healthcare, Fortis, ...
Read more: Sceptre Medical India recognized as 'India's Most Admirable Healthcare Brand-2020' in the ...

Pharma Reviews: Zydus Cadila gets US FDA nod for potassium chloride extended-release tablets

Zydus Cadila has received final approval from the USFDA to market ... Indian pharma industry will be among the first to develop and supply low cost ...
Read more: Zydus Cadila gets US FDA nod for potassium chloride extended-release tablets

Pharma Reviews: Indian pharma industry will be among the first to develop and supply low cost vaccines for COVID ...

Gowda was addressing a Webinar organised by Invest India Pharma Bureau and Department of pharmaceuticals on #EIF2020 Medical Devices and ...
Read more: Indian pharma industry will be among the first to develop and supply low cost vaccines for COVID ...

Pharma Reviews: Russian coronavirus vaccine to arrive in India in November, clearances pending

Prasad also said the company had received approval from the Drug Controller General of India (DCGI) to conduct trials. He said Russian vaccine is the ...
Read more: Russian coronavirus vaccine to arrive in India in November, clearances pending

Pharma Reviews: Market Live Updates: Sensex trades flat, Nifty around 11550; pharma stocks rally

Market Live Updates: Sensex trades flat, Nifty around 11,550; pharma ... is also learnt to be in talks to bring coronavirus vaccine Sputnik V in India.
Read more: Market Live Updates: Sensex trades flat, Nifty around 11550; pharma stocks rally

Pharma Reviews: From Being A Net Importer, India Now Manufactures Over 5 Lakh PPE Kits Per Day: Union Minister ...

Gowda also lauded the contribution of Indian pharma industry during the testing time of COVID and expressed confidence that it will be among the first ...
Read more: From Being A Net Importer, India Now Manufactures Over 5 Lakh PPE Kits Per Day: Union Minister ...

Pharma Reviews: Morning News Call - India, September 18

... Pharmaceuticals Secretary Navdeep Rinwa is likely to participate in PHD Chamber of Commerce's webinar on the outlook for the pharma industry.
Read more: Morning News Call - India, September 18

Pharma Reviews: JSA, CAM lead on Creador ₹250 crore investment in pharma packaging firm Shriji Polymers

Malaysia-based private equity firm Creador, has invested ₹250 crore in Indian pharmaceutical packaging firm Shriji Polymers (India) Ltd. The ...
Read more: JSA, CAM lead on Creador ₹250 crore investment in pharma packaging firm Shriji Polymers

Pharma Reviews: Sadananda Gowda lauds contribution of Indian pharma industry during COVID pandemic

He expressed confidence that Indian pharma industry will be among the first one to develop and supply low cost vaccines for this pandemic. The Minister ...
Read more: Sadananda Gowda lauds contribution of Indian pharma industry during COVID pandemic

Pharma Reviews: Maharashtra reported its second-highest surge of 24619 new COVID19 cases on Thursday

NextGowda expects Indian pharma industry to be among the first one to develop and supply low ... India has Air Bubble Agreements with 10 Countries.
Read more: Maharashtra reported its second-highest surge of 24619 new COVID19 cases on Thursday

Pharma Reviews: Post KKR's acquisition, JB Chemicals stock takes wings

Unlike some other smaller pharmaceutical companies, it has a few ... a decent growth even as the overall Indian Pharma Market growth has been ...
Read more: Post KKR's acquisition, JB Chemicals stock takes wings

Pharma Reviews: CSIR Teams with Aurobindo Pharma to Develop COVID-19 Vaccine

Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited have joined hands to develop SARS-CoV-2 vaccine in India.
Read more: CSIR Teams with Aurobindo Pharma to Develop COVID-19 Vaccine

US FDA News: Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may have
Read more: Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 17, 2020

FDA’s actions on a new abbreviated drug application approval and a warning to consumers and health care professionals in its ongoing response to the COVID-19 pandemic.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 17, 2020

Pharma Reviews: Covid-19 anywhere is covid-19 everywhere: Mark Suzman

Our foundation is also working with Indian pharma companies to look at the ... This expertise gives India's vaccine industry a significant advantage in ...
Read more: Covid-19 anywhere is covid-19 everywhere: Mark Suzman

Pharma Reviews: This Canadian startup plans to repurpose Cannabis-derived drug for cardiac diseases linked to ...

Akseera Pharma, a Canadian startup founded by entrepreneurs of Indian origin, is planning to begin clinical trials and manufacturing of Cannabidiol ...
Read more: This Canadian startup plans to repurpose Cannabis-derived drug for cardiac diseases linked to ...

Pharma Reviews: Russia Confirms Deal With India To Supply 100 Million Doses Of 'Sputnik V' COVID Vaccine

“The RDIF and Dr Reddy''s Laboratories Ltd, a global pharmaceutical company with headquarters in India, have agreed to supply 100 million doses of ...
Read more: Russia Confirms Deal With India To Supply 100 Million Doses Of 'Sputnik V' COVID Vaccine

Pharma Reviews: SC: Centre's nod for Remdesivir and Favipiravir for Covid-19, asks petitioner to study rules

The petitioner sought prosecution of Indian companies for offences of cheating and criminal conspiracy besides under the provisions of the Drug Act, ...
Read more: SC: Centre's nod for Remdesivir and Favipiravir for Covid-19, asks petitioner to study rules

Pharma Reviews: FICCI HEAL 14th edition focuses on post COVID-19 challenges

Federation of Indian Chambers of Commerce and Industry (FICCI) HEAL, 14th ... national and international leaders from healthcare and allied industries.” ... of Pharma Industry; Realizing Atmanirbhar Bharat through Make in India; ...
Read more: FICCI HEAL 14th edition focuses on post COVID-19 challenges

Pharma Reviews: Market Live Updates: Indices off day's low in volatile trade; Dr Reddy's Labs top gainer, metals ...

Buzzing Stock: Ircon International share price jumped 3 percent after the company bags order worth Rs 1,900 crore from Indian Railways.
Read more: Market Live Updates: Indices off day's low in volatile trade; Dr Reddy's Labs top gainer, metals ...

Pharma Reviews: SC adjourns plea seeking CBI case against 10 pharma firms for manufacturing COVID-19 drugs ...

... against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir, allegedly as medicines to treat COVID-19 patients ...
Read more: SC adjourns plea seeking CBI case against 10 pharma firms for manufacturing COVID-19 drugs ...

Pharma Reviews: 4 Industries Benefiting from the Scientific Expense Management – Pharma, IT, FMCG, Banking

The HR industry in India is continuously enabling and driving the ... Pharmaceutical Industry- According to a report by the Indian Brand Equity ...
Read more: 4 Industries Benefiting from the Scientific Expense Management – Pharma, IT, FMCG, Banking

Pharma Reviews: UQC standardisation processes disturb pharma exports, experts raise concerns

The Indian pharma industry is facing issues at the customs clearance due to implementation of mandatory standardisation of Unit Quantity Codes ...
Read more: UQC standardisation processes disturb pharma exports, experts raise concerns

Pharma Reviews: Dr Reddy's Lab Ties up with Russia for Phase 3 Trials of Sputnik V Vaccine, to Procure 10 Crore ...

Indian pharma giant Dr. Reddy's Laboratory Ltd. has partnered with the ... the two other Indian companies that have tied up with vaccine developers; ...
Read more: Dr Reddy's Lab Ties up with Russia for Phase 3 Trials of Sputnik V Vaccine, to Procure 10 Crore ...

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 16, 2020

Coronavirus (COVID-19) Update: Daily Roundup for September 16, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 16, 2020

Pharma Reviews: Russia's RDIF collaborates with Dr Reddy's Laboratories for Sputnik V vaccine trials, distribution ...

“The RDIF and Dr Reddy's Laboratories Ltd, a global pharmaceutical company with headquarters in India, have agreed to supply 100 million doses of ...
Read more: Russia's RDIF collaborates with Dr Reddy's Laboratories for Sputnik V vaccine trials, distribution ...

Pharma Reviews: Interview | Rs 6.9 lakh cr sitting idle in banks can be given to stressed MSMEs: Niranjan Hiranandani

The government of India like the governments all across the world have ... During the lockdown, Indian pharmaceutical companies also took a lead ...
Read more: Interview | Rs 6.9 lakh cr sitting idle in banks can be given to stressed MSMEs: Niranjan Hiranandani

US FDA News: Becton Dickinson (BD) CareFusion 303 Inc. Recalls Alaris™ Syringe and Alaris™ PCA Modules Due to Potential Incorrect Display of Syringe Types and/or Sizes

The Alaris System is an infusion system. If parts of the PCA or Syringe Modules are damaged, incorrect syringe details may show, leading to inaccurate infusions.
Read more: Becton Dickinson (BD) CareFusion 303 Inc. Recalls Alaris™ Syringe and Alaris™ PCA Modules Due to Potential Incorrect Display of Syringe Types and/or Sizes

Pharma Reviews: Pharma sector offers potential for high exports but India overly relies on China for drug ingredients

With strong drug manufacturing expertise at low cost, India is one of the largest suppliers of generic drugs and vaccines and some Indian manufacturers ...
Read more: Pharma sector offers potential for high exports but India overly relies on China for drug ingredients

Pharma Reviews: Time for pharma cold chain to commit for quality, temp integrity over costs

The Indian pharmaceutical cold chain market is highly fragmented and price-sensitive with many small players offering temperature-controlled ...
Read more: Time for pharma cold chain to commit for quality, temp integrity over costs

Pharma Reviews: Interview | Rs 6.9 lakh cr sitting idle in banks can be given to stressed MSMEs: Niranjan Hiranandani

During the lockdown, Indian pharmaceutical companies also took a lead and exported several life-saving drugs to many developed countries.
Read more: Interview | Rs 6.9 lakh cr sitting idle in banks can be given to stressed MSMEs: Niranjan Hiranandani

Pharma Reviews: CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines

CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines ... The Council of Scientific and Industrial Research (CSIR) and Aurobindo ... CSIR labs with industry for the development of vaccines will amplify India's efforts ...
Read more: CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines

Pharma Reviews: India's Dr Reddy's Lab to get 100 million doses of Russia's COVID-19 vaccine after regulatory ...

Russia is likely to sell 100 million doses of its COVID-19 vaccine — Sputnik-V — to Indian pharmaceutical Dr Reddy's Laboratories; According to the ...
Read more: India's Dr Reddy's Lab to get 100 million doses of Russia's COVID-19 vaccine after regulatory ...

Pharma Reviews: SC adjourns for two weeks plea seeking CBI case against pharma firms

Sharma, through his plea, sought prosecution of the Indian companies for cheating and criminal conspiracy besides under the provisions of the Drug ...
Read more: SC adjourns for two weeks plea seeking CBI case against pharma firms

Pharma Reviews: Market LIVE: Trade choppy; Sensex soars 200 points, Nifty eyes 11600

Track this space for latest stock market updates: ... Sputnik-V, to a major listed pharmaceutical company in India, a source close ... Nifty Pharma up 1%.
Read more: Market LIVE: Trade choppy; Sensex soars 200 points, Nifty eyes 11600

Pharma Reviews: SC adjourns for two weeks plea seeking CBI case against pharma firms

... Investigation (CBI) against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir, allegedly as medicines to treat ...
Read more: SC adjourns for two weeks plea seeking CBI case against pharma firms

Pharma Reviews: FICCI announces its annual healthcare conference, FICCI HEAL 2020

Changing landscape of Pharma Industry;Realizing Atmanirbhar Bharat through Make in India;Diagnostics- Pandemic & Beyond;Best Practices for ...
Read more: FICCI announces its annual healthcare conference, FICCI HEAL 2020

Pharma Reviews: Market Live Updates: Indices trade higher with Nifty above 11550; auto, pharma stocks gain

Air India August market share at 9.8 percent against 9.1 percent. IndiGo August market share at 59.4 percent against 60.4 percent (MoM). SpiceJet ...
Read more: Market Live Updates: Indices trade higher with Nifty above 11550; auto, pharma stocks gain

Pharma Reviews: Why COVID-19 presents a golden opportunity to Indian pharma firms

India is emerging as the epicentre of vaccine manufacturing. Top pharma companies in the country are supplying basic and advanced vaccines to nearly ...
Read more: Why COVID-19 presents a golden opportunity to Indian pharma firms

Pharma Reviews: Impact of COVID-19 on Indian Pharma Industry: Minister apprises parliament

New Delhi: The impact of fatal COVID-19 on the domestic pharma industry was brought up in the recent Lok Sabha session, wherein, the Union ...
Read more: Impact of COVID-19 on Indian Pharma Industry: Minister apprises parliament

Pharma Reviews: Stocks To Watch: Aurobindo Pharma, Future Enterprises, Hexaware, Indiabulls Housing ...

Aurobindo Pharma: Government's Biotechnology Industry Research ... the vaccine manufacturing platform in India by supporting Aurobindo Pharma's ...
Read more: Stocks To Watch: Aurobindo Pharma, Future Enterprises, Hexaware, Indiabulls Housing ...

Pharma Reviews: India must seize chance to become 'atma nirbhar'

The industry did well in the formulations and indigenous medicines sector but with gradual doses of liberalisation, the pharma market began to be ...
Read more: India must seize chance to become 'atma nirbhar'

US FDA News: Coronavirus (COVID-19) Update: FDA Publishes Comparative Performance Data for COVID-19 Molecular Diagnostic Tests

The FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests.
Read more: Coronavirus (COVID-19) Update: FDA Publishes Comparative Performance Data for COVID-19 Molecular Diagnostic Tests

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 15, 2020

FDA issues two warning letters in its ongoing response to the COVID-19 pandemic.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 15, 2020

Pharma Reviews: GSK India, RCB mark milestone of academia-industry initiative

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Pharmaceutical Ltd.) in collaboration with the Regional Centre for Biotechnology (RCB) has completed ...
Read more: GSK India, RCB mark milestone of academia-industry initiative

Pharma Reviews: 'Leaders in govt and pharma must ensure that everyone can access vaccines'

“We need leaders in government and the pharmaceutical industry to ensure that everyone, regardless of ... The Indian Express is now on Telegram.
Read more: 'Leaders in govt and pharma must ensure that everyone can access vaccines'

Pharma Reviews: Aurobindo Pharma ties up with Biotechnology Industry Research Assistance Council for vaccine

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the pharma firms in India ...
Read more: Aurobindo Pharma ties up with Biotechnology Industry Research Assistance Council for vaccine

US FDA News: FDA issues first injunction under Produce Safety Rule to Illinois-based food manufacturer for repeated food safety violations

FDA announced that an Illinois-based food manufacturer has agreed to stop production until it undertakes remedial action and complies with the Federal Food, Drug, and Cosmetic Act.
Read more: FDA issues first injunction under Produce Safety Rule to Illinois-based food manufacturer for repeated food safety violations

Pharma Reviews: Aurobindo Pharma ties up with BIRAC to develop Covid-19 vaccine

BIRAC has facilitated the establishment of 'the r-VSV vaccine' manufacturing platform for the first time in India by supporting Aurobindo Pharma's ...
Read more: Aurobindo Pharma ties up with BIRAC to develop Covid-19 vaccine

Pharma Reviews: Can India still be 'pharmacy of the world' while reducing import dependence of APIs?

New Delhi: After Covid-19 pandemic, India's focus to reduce import dependence of Active Pharmaceutical Ingredients (APIs) and key starting material ...
Read more: Can India still be 'pharmacy of the world' while reducing import dependence of APIs?

Pharma Reviews: GSK-Regional Centre for Biotechnology completes 1 year of academia-industry initiative

... offers full PhD courses in Biostatistics and Bioinformatics to equip Indian students for a career in a data and AI-driven pharma research ecosystem.
Read more: GSK-Regional Centre for Biotechnology completes 1 year of academia-industry initiative

Pharma Reviews: GSK India, RCB mark the milestone of academia-industry initiative

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Pharmaceutical Ltd.) in ... to equip Indian students for a career in a data and AI-driven pharma research ...
Read more: GSK India, RCB mark the milestone of academia-industry initiative

Pharma Reviews: Life sciences companies revisiting their EU strategies want to understand the Irish proposition better

India mainly imports IT devices, plastics, pharma products, scientific and medical equipment from Ireland. What makes Ireland, 'the' destination for Indian ...
Read more: Life sciences companies revisiting their EU strategies want to understand the Irish proposition better

Pharma Reviews: GSK Pharmaceuticals (India) in collaboration with Regional Centre for Biotechnology completes ...

The first webinar was held today. Like the program, these webinars are also an academia-industry collaboration in which experts from the private sector ...
Read more: GSK Pharmaceuticals (India) in collaboration with Regional Centre for Biotechnology completes ...

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 14, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 14, 2020

US FDA News: Becton Dickinson (BD) CareFusion 303 Recalls Alaris System Infusion Pumps Due to Damaged Inter-Unit Interface Connectors, Loose or Missing Battery Screws and A Broken Upper and Lower Hinge Posts and Membrane Frame

The Alaris System Infusion Pump is the foundation of the infusion system. Multiple models are being recalled due to damaged IUI Connectors, loose or missing Battery Screws and broken upper and lower hinge posts and membrane frame.
Read more: Becton Dickinson (BD) CareFusion 303 Recalls Alaris System Infusion Pumps Due to Damaged Inter-Unit Interface Connectors, Loose or Missing Battery Screws and A Broken Upper and Lower Hinge Posts and Membrane Frame

US FDA News: Becton Dickinson (BD) CareFusion 303, Inc. Recalls Alaris™ System PC Unit and PC Unit Front Case Keypad Replacement Kits Due to Risk of Stuck or Unresponsive Keys

The Alaris System is an infusion system. The PC Unit Keys may become stuck or unresponsive and may lead to an infusion delay or prevent clinicians from changing fluid or medication infusions on the affected device.
Read more: Becton Dickinson (BD) CareFusion 303, Inc. Recalls Alaris™ System PC Unit and PC Unit Front Case Keypad Replacement Kits Due to Risk of Stuck or Unresponsive Keys

Pharma Reviews: Future of Pharmaceutical industry in India

Indian pharma industry did well in formulations and indigenous medicines sector but with the gradual liberalisation, the pharma market was flooded ...
Read more: Future of Pharmaceutical industry in India

Pharma Reviews: Exports offer lifeline as domestic market flounders

Ceramic tile-makers in Morbi — India's largest cluster of ceramics ... Although the pharmaceutical sector was not hit as hard as many others, it is still ...
Read more: Exports offer lifeline as domestic market flounders

Pharma Reviews: Indian Pharma sees decline in August 2020, anti-infectives, respiratory segments see major ...

New Delhi: Amid the ongoing COVID-19 crisis, the month of August remained unfavorable for the Indian pharmaceutical market as data from market ...
Read more: Indian Pharma sees decline in August 2020, anti-infectives, respiratory segments see major ...

Pharma Reviews: Indian Pharma to become $100 BN industry, says Antony Prashant, Partner of Deloitte India

Deloitte in its discussion paper says 'Indian Pharmaceutical industry has 'potential to be a USD 100 billion pharma factory of the world'. Did you know ...
Read more: Indian Pharma to become $100 BN industry, says Antony Prashant, Partner of Deloitte India

Pharma Reviews: SCHOTT AG appoints Pawan Kumar Shukla as MD for Indian pharma glass business

While the domestic market is our key focus, our India plant also caters to the Asian market, thereby contributing to the pharma industry and the Indian ...
Read more: SCHOTT AG appoints Pawan Kumar Shukla as MD for Indian pharma glass business

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 11, 2020

FDA issues a temporary guidance and an FDA Voices in its ongoing response to the COVID-19 pandemic.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 11, 2020

Pharma Reviews: How Indian pharma can grow to be a $100-bn industry

India is literally called the pharmacy of the world. How can we increase India's market share in the global pharma industry? Will one need to invest more ...
Read more: How Indian pharma can grow to be a $100-bn industry

Pharma Reviews: German Glassmaker SCHOTT AG Appoints New Managing Director For Indian Pharma Glass ...

While the domestic market is our key focus, our India plant also caters to the Asian market, thereby contributing to the pharmaceutical industry and the ...
Read more: German Glassmaker SCHOTT AG Appoints New Managing Director For Indian Pharma Glass ...

Pharma Reviews: Indian pharma has potential to be $100bn pharma factory of world: Deloitte

India's Pharmaceutical sector is estimated to be at USD 40 billion with USD 32 billion coming from formulation & USD 8 billion coming from API (Active ...
Read more: Indian pharma has potential to be $100bn pharma factory of world: Deloitte

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup September 10, 2020

FDA’s action on a warning letter in its ongoing response to the COVID-19 pandemic.
Read more: Coronavirus (COVID-19) Update: Daily Roundup September 10, 2020

US FDA News: Medek, LLC. Issues Voluntary Nationwide Recall of M Hand Sanitizer Due to Potential Presence of Methanol (Wood Alcohol) and Subpotent Ethanol Levels

Medek, LLC is voluntarily recalling all lots of M Hand Sanitizer Alcohol Antiseptic 80% 128 oz/3,785 mL to the consumer level. FDA analysis found the M Hand Sanitizer to contain methanol and be sub-potent for ethanol. Substantial methanol exposure can result in nausea, vomiting, headache, blurred v
Read more: Medek, LLC. Issues Voluntary Nationwide Recall of M Hand Sanitizer Due to Potential Presence of Methanol (Wood Alcohol) and Subpotent Ethanol Levels

US FDA News: FDA Warns Website Operators Illegally Selling Opioids to Consumers

FDA has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids online. Misbranded opioids include those offered for sale without a prescription, as well as opioids dispensed without adequate directions for use.
Read more: FDA Warns Website Operators Illegally Selling Opioids to Consumers

Pharma Reviews: Motilal Oswal: Indian Pharma Market Declines In August After Posting Muted Growth In July 2020

The Indian Pharma market (IPM) declined by 2.2% YoY in August 2020 (versus muted growth of 0.2% YoY in July 2020). The volume decline of 9.2% ...
Read more: Motilal Oswal: Indian Pharma Market Declines In August After Posting Muted Growth In July 2020